Government considers widening ban on puberty blockers for children to include cross-sex hormones used for gender transition
Wes Streeting is considering extending the ban on puberty blockers for under-18s to include controversial cross-sex hormones, the High Court has heard.
It came as judges today rejected a legal challenge that would have forced the Health Secretary to include the gender drugs in the ban over concerns about their safety.
Lawyers representing a prominent 'detranstitioner' argued that the Health Secretary's approach to banning puberty blockers for children but not cross-sex hormones is 'irrational and unlawful'.
Keira Bell - who took the Tavistock gender clinic to court after she was given puberty blockers aged 16 - sought a Judicial Review against Mr Streeting and NHS England over the move to continue prescribing 'masculinising and feminising hormones'.
Zoe Gannon, representing Ms Bell and two other claimants, argued that the decision-making process within the Department of Health and Social Care (DHSC) was 'demonstrably flawed' and urged the court to allow the challenge 'in light of the risks posed to children'.
However Ian Steele, representing the DHSC, told the court on Wednesday that the legal bid to extend the ban was 'premature and academic' as the use of cross-sex hormones in children is now under review.
He said: 'The defendant [Mr Streeting] has instead rationally chosen to keep that possibility under review, and at his request, NHS England has established an expert working group to advise him, which is occurring in parallel with further work also being undertaken by the defendant's officials with a view to assisting his decision making.
'In light of that ongoing review, this claim is both premature and academic.' The working group is expected to report back in July.
This was welcomed by Ms Bell yesterday, who said she was 'relieved' that Mr Streeting is now considering a ban, adding: 'These powerful drugs should not be given to children.'
She said: 'Although the Secretary of State's decision to actively review making a ban on these drugs outside the NHS is long overdue, it is welcome that he is now taking a lead.
'The safety of vulnerable children and young people should be a first priority. It now looks like that is beginning to happen.'
This came despite the High Court yesterday [WEDS] rejecting Ms Bell's challenge, with judges accepting that it would be 'premature' to allow the claim given the DHSC has established a working group to examine the use of the gender drugs.
Dismissing the bid, Lady Justice Whipple, sitting with Mr Justice Johnson, said there was a need for a 'careful' approach to decision making in this area, and that is 'what the Secretary of State is doing'.
She added: 'This is an immensely difficult and sensitive area of policy formation where there are strong and genuinely held views on each side of the debate and where there is no consensus.'
Lady Justice Whipple also found that it was not 'unreasonable or irrational' for the Government to address the question of puberty blockers first before considering cross-sex hormones later.
Paul Conrathe, a lawyer representing the claimants, told the Mail: 'Although my clients were not granted permission to bring a Judicial Review, they are delighted that the litigation has led to the Secretary of State setting up a working group to urgently review the possibility of a ban on cross-sex hormones being prescribed to children.
'This is long overdue as vulnerable children have been accessing powerful, life-changing, irreversible drugs from activist clinicians in the private sector.'
It comes after the Health Secretary announced an indefinite ban on puberty blockers for under-18s in December due to the 'unacceptable safety risk' they pose.
Mr Streeting said the decision had been taken following the 'scandal' of thousands of children being handed the puberty-halting medication without proof it is safe.
It came after the landmark Cass Review found that children questioning their gender had been 'let down by a lack of research' and 'remarkably weak' evidence on medical interventions.
Baroness Cass advised 'extreme caution' around the use of hormone treatment in under-18s and said that there should be a clear clinical rationale for not waiting until somebody reaches 18.
A DHSC spokesman said: 'Children's healthcare must always be led by evidence. That is why this government is implementing the recommendations from the Cass Review and acted immediately to extend the puberty blockers ban and make it permanent.
'We are continuing our work with the NHS to reform gender services to ensure young people receive timely, holistic care and support, while reviewing the use of cross-sex hormones.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
16 minutes ago
- Daily Mail
GP issues warning over new Covid symptom amid fears Nimbus variant will sweep the UK this summer
Doctors are urging anyone with a 'razor blade' throat that they could have a new and highly contagious Covid variant. Dubbed 'Nimbus', the strain is descended from the super virulent Omicron, with 13 cases having already been found in the UK, following a surge in cases in China, Singapore and Hong Kong. Whilst experts say Nimbus symptoms are broadly similar to earlier versions of the virus a 'razor blade sore throat' could be a key sign of the new variant. According to Dr Naveed Asif, a GP at The London General Practice, this distinctive symptom is characterised by a sharp, stabbing pain when swallowing, often at the back of the throat. Other symptoms linked to the strain include redness in the back of the mouth and swollen neck glands as well established common Covid symptoms like fever, muscle aches and congestion. 'However, symptoms can vary widely so vigilance is key', Dr Asif told Manchester Evening News. According to the NHS, Covid symptoms include a high temperature, a new continuous cough, a loss or change to sense of smell or taste, shortness of breath and feeling sick. Whilst only 13 British cases of Nimbus have been identified so, these figures likely underestimate how far the variant has spread. This is because the number of Covid tests carried out has massively decreased since the height of pandemic and lockdown. Data from the UK Health Security Agency (UKHSA) shows the number of people testing positive for Covid has hit record levels this year and is already 97 per cent higher than numbers recorded in March. Experts have also warned that the new strain could lead to a surge in Covid cases over the summer and have urged the vulnerable to get vaccinated. Even those who were previously vaccinated or infected could be at risk of the catching the virus as previously built-up immunity fades over time. Professor Lawrence Young, a virologist at Warwick University, put the potential surge in cases down to warmer weather and busier social lives. 'We are very likely to see a spike of infections over the next couple of months, possibly by later this month or in July. But it's difficult to predict the level of this infection wave,' he told The i Paper. 'Population immunity, either from vaccination or previous infection, is waning and, unlike other respiratory viruses such as flu, the Covid virus continues to spread in hot and humid weather,' he said. Lab studies suggest Nimbus can infect human cells more efficiently than previous strains, making it more likely to infect people. However, there is currently no evidence Nimbus is more likely to cause severe illness or death in those it infects compared to previous variants. But infection with the virus can still be deadly for more vulnerable groups. Covid was a factor in the deaths of just over 300 people in England in May, according to the latest official figures. Experts have also said that current Covid vaccines, which have been reformulated to combat Omicron descendants, are expected to remain effective against Nimbus. According to the World Health Organisation, Nimbus, scientifically known as NB.1.8.1, now accounts for 10.7 per cent of Covid infections worldwide, compared to just 2.5 per cent a month prior. Dr Gayatri Amirthalingam, UKHSA's deputy director, said the organisation was keeping a close eye on Nimbus. 'UKHSA is monitoring all available data relating to SARS-CoV-2 variants in the UK and abroad, and we continue to publish our findings in our regular Flu and Covid-19 surveillance reports,' she said. 'NB.1.8.1 has been detected in small numbers in the UK to date, but international data suggests that it is growing as a proportion of all Covid-19 cases.' Currently adults over the age of 75, care home residents, and those aged six months and over who have weakened immune systems are all eligible for a free Covid vaccine across the UK. This includes organ, bone marrow or stem cell transplant patients, people living with HIV, cancer patients undergoing chemotherapy or radiotherapy and those with genetic disorders affecting the immune system. UKHSA data suggests people who had a Covid jab as part of last spring's booster campaign were 45 per cent less likely to need hospital care for the virus in the weeks that followed compared to the unvaccinated. The agency has urged all people eligible for a vaccine to get jabbed to protect themselves from both NB.1.8.1 and Covid in general.
Daily Mail
16 minutes ago
- Daily Mail
All the conditions that mean you wouldn't get called up to the army
By Diabetes , chronic migraines, Raynaud's. They're just three out of a 60-strong list of conditions that would rule you out of serving in the Army. It comes after the UK's most senior soldier warned yesterday that a 'citizen army' would be needed for any direct confrontation with Vladimir Putin . Although he stopped short of backing conscription, General Sir Patrick Sanders said preparing for war against Russia should be a 'whole-of-nation' undertaking, including what he described as 'national mobilisation'. High blood pressure High blood pressure, known medically as hypertension, is estimated to affect 14.4million people in the UK — a quarter of all adults. Of these, a staggering four million are thought to be undiagnosed, as they have never been tested. The condition is flagged among 'cardiovascular problems' by the British Army. Checks are available for free via GP surgeries and, if you're over 40, at many pharmacies. As a general guide, ideal blood pressure is considered to be between 90/60 and 120/80 — or below 150/90 if you're aged over 80. High blood pressure, meanwhile, is considered to be 140/90 — or 150/90 or over if you're aged over 80. Between 120/80 and 140/90 means that you are at risk of developing the condition if you don't take preventative measures. Piles Constipation, pushing too hard when pooing, heavy lifting and pregnancy are some of the causes of haemorrhoids, also known as piles, which take the form of lumps in and around the anus, according to the NHS . Bright red blood after you poo, an itchy anus and lumps around your anus are signs you may be suffering from piles, which are swollen blood vessels. For some the lumps are temporary and get better after a few days once diet and bowel habits, go back to normal. But if symptoms worsen or last more than a week, a GP may prescribe stronger medicines. They may also check your symptoms are not being caused by something else. Army chiefs warn against joining or delaying your application to join if suffering from 'active haemorrhoids'. Among the common hospital treatments include rubber band ligation — a band placed around your piles to make them drop off — and sclerotherapy, a liquid injected into your piles to make them shrink. Up to 80 per cent of people suffer piles at some point in their lives, it is estimated. Migraines Migraines typically feel like a very bad headache, with a throbbing pain on one side of the skull. They can last anywhere between hours or days. Sufferers can get warning signs before a migraine strikes, such as stiff neck, fatigue or vision changes like seeing zigzag lines (an 'aura'). An estimated one in seven Brits suffer from some form of migraine. However, in September health officials revealed around 13,000 Brits suffering from severe and untreatable migraines would benefit from a pill that can prevent attacks. Food intolerances A food allergy requiring you to avoid some foods or an intolerance is among another common reason that may prevent or delay you from joining, according to the British Army. However, it notes: 'You can still apply to join the army even if your medical history includes one or more of these conditions. 'The medical team assess everyone individually, and make their decisions based on their professional opinion in keeping with prescribed army standards.' Unlike with most other forms of chronic illness, people with allergies are usually fit between attacks and may have high levels of personal fitness. However, the Army cannot guarantee to serve food which is free from nuts or other potential allergens. A soldier suffering an allergic reaction while on deployment may also tie up one or more other personnel to look after them. Diabetes More than five million people in the UK are thought to have diabetes of some form. Being fat can lead to type 2, the most common type. It occurs when the body does not produce enough insulin (a hormone which controls absorption of sugar into the blood) or when cells do not react to insulin properly. Type 1, on the other hand, has nothing to do with being overweight. The lifelong condition is caused by the body's immune system mistakenly attacking and destroying cells that produce insulin. Excess fat in the liver increases the risk of developing type 2 diabetes as the buildup makes it harder to control glucose levels, and also makes the body more resistant to insulin. Raynaud's With Raynaud's, freezing temperatures can trigger miniature spasms in your blood vessels, cutting off the blood supply to the outermost parts of the body. Usually the phenomenon attacks the fingers but sometimes also the toes, ears and tip of the nose. In rare cases, it can affect your nipples. Areas affected will turn white and eventually blue. Then, as blood flow returns, they morph into a shade of red. Attacks – which can cause a burning or tingling sensation and numbness – can last anywhere from a few minutes to an hour. Warming up the fingers, or anywhere that has been affected, stops a flare-up in its tracks. Up to 20 per cent of adults are thought to have Raynaud's. Although attacks peak in the cold winter months, symptoms can be triggered by every day tasks such as taking food out of the freezer, air conditioning, or even stress — all of which cause blood vessels to contract. A small number of patients go on to develop a more serious connective tissue disease, scleroderma, which can cause disability and even prove fatal if not treated properly. As well as warming up your hands and toes, Raynaud's can also be thwarted with a drug called nifedipine, which improves circulation.
The Independent
21 minutes ago
- The Independent
NHS trust cleared of corporate manslaughter after death of woman
An NHS trust has been cleared of corporate manslaughter after a young woman killed herself in a mental health unit after more than 10 similar attempts at self-harm. Jurors at the Old Bailey last Wednesday found that North East London NHS Foundation Trust (NELFT) was not responsible for the death of Alice Figueiredo, 22, but had 'failed to ensure the safety of a non-employee', it can now be reported. On Monday, ward manager Benjamin Aninakwa, 53, of Grays in Essex, was cleared of manslaughter by gross negligence, but was found guilty of failing to take reasonable care for the health and safety of patients on the ward. Jurors deliberated for 125 hours and 22 minutes to reach their verdicts. Ms Figueiredo died at Goodmayes Hospital, Redbridge, on July 7 2015, after a failure to remove plastic items from the communal toilets in the Hepworth Ward that had been used in repeated earlier attempts at self-harm. The jury heard Ms Figueiredo had been a 'bright and gifted' woman, the head girl at her school who had set up a mentoring system to support her peers. Her family said she was loved for her 'warmth, kindness and joyful character', the court was told. She was first admitted to the Hepworth Ward in May 2012 with a diagnosis including non-specific eating disorder and bipolar affective disorder, jurors heard. During her time on the acute psychiatric ward, the trust failed to remove plastic items from the communal toilets or keep them locked, even though she repeatedly used the items to try to kill herself. She had used plastic from the toilets to self-harm on at least 10 previous occasions. However, the court heard of eight more incidents involving similar materials before Ms Figueiredo killed herself. The suicide attempts were recorded in ward notes and other hospital records. Aninakwa, who was subject to a performance improvement plan, had failed to remove plastic that could be used for self-harm and failed to ensure incidents of self-harm were recorded, considered and addressed, jurors heard. Aninakwa and the trust had denied wrongdoing but declined to give evidence. The nurse had denied knowing about all the previous suicide attempts and said what action he took was overruled by management. It was claimed on his behalf that there was heightened observation to prevent incidents of self harm, which mitigated the fact plastic material was not removed and the communal toilets not locked. The trust also denied knowledge of the incidents, claiming the ward had not reported them. The process of removing plastics from the communal toilets was complicated by issues of infection control and preventing staff from being exposed to hazardous material in the bins, such as needles. The investigation into Ms Figueiredo's death began in 2016 but charges were not brought until September 2023. The first corporate manslaughter trial against an NHS trust collapsed in 2016 after a judge ruled there was no case to answer. Maidstone and Tunbridge Wells NHS Trust was accused over the death of schoolteacher Frances Cappuccini, 30, the first prosecution of a health service body since the offence was introduced in 2008. She went into cardiac arrest and died after an emergency Caesarean section at Tunbridge Wells Hospital in Pembury, Kent, on October 9 2012. The sentence for corporate manslaughter is a fine of between £180,000 and £20 million depending on the size of the organisation. Judge Richard Marks KC thanked jurors for their 'immense hard work' and discharged them from jury service for the rest of their lives. He thanked Ms Figueiredo's parents for their attendance throughout the trial, saying: 'It speaks volumes for both of you, and the immense love you have for Alice.' 'I hope this provides some consolation and some closure,' he added.
